-
For those who want a disposable system without needles this is a solution to the big stick. Two different medications have now been approved to be used with the device. The device is small and worn underneath clothing so it doesn’t stand out and can hide. The device is to be used with...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Mar 2 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, FDA, Diabetes, insulin, R and D, Valeritas, needle free, in-Patch
-
K2, Spice, Blaze and Red X Dawn are some of the products mentioned below and users smoke the contents for the buzz. Emergency rooms across the US have been experiencing patients with over doses of the “fake pot”. High blood pressure, elevated heart rates, vomiting are some of the side effects...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Mar 1 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, drugs, DEA, side effects AstraZeneca, K2, Blaze, fake pot, Red X Dawn, Ban
-
This is a big deal to not confuse the two strengths as this the drug is used to thin blood. The upside though is that the tablets look different and hopefully the pharmacists who are responsible for filling our prescriptions will notice this if they run across one of the recalled bottles. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 23 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, warfarin, Recalls, blood thinners, pharmacists, Upjohn, luddites
-
This acquisition has been in the news since I believe last August with board rejections and now it appears it has finally resolved and Genzyme will be purchased by Sanofi. This is a huge price tag at $20 Billion. You may or may not be familiar with Genzyme but back in 2009 they were in the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 16 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Biotech, Massachusetts, Mergers and Acquisitions, Sanofi-Aventis, Genzyme, research and development collaboration
-
The company found this on their own without FDA interaction and I would guess after all the recalls, they are probably going through everything with a fine tooth comb. This is not a recall that affects a real large group of consumers but still it’s one more product found not to be up to standards...
-
This is a big deal as we don’t manufacture the drug in the US, and on top of that we don’t have Propofol manufactured in the US either. The 2 drugs are the #1 and #2 choices and used in hospitals all over the country. Everyone may remember Propofol from the Michael Jackson case, but it is...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 10 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, drugs, healthcare, FDA, Recalls, Teva, Michael Jackson, Diprivan, Propofol, Novartis, anesthesia, etomidate, Pentothal, Hospira
-
If you have been a reader here long enough at the Quack then you have probably read one of my articles about the use of bar codes on drugs and medical devices. We have somewhat of a step in this direction, but lots of lack luster still missing. You can read the short paragraph below and see...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Tracking, Pharma, FDA, cell phones, Safety, information, Scanning, Bar Codes, MDs, adverising, FadeMark
-
The doctor and his wife are both researchers and have written and published 8 scientific articles about PROPOXYPHENE since 1993. He feels that the drug has killed more people than any other drug in history. The drug was invented by Eli Lilly in 1953. Darvon is an opiate and in...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Lawsuit, FDA, Blood Tests, narcotics, Darvocet, Darvon, propoxyphene, Xanodyne Pharma, Europe CE, autopsy, Jonasson, Sweden
-
Patrick Soon-Shiong M.D. is the Los Angeles billionaire investor who has scooped up the company. Overall the product is a good thing as far as the reminder system and keep folks on track. My only concerns is the privacy factors and the data that it creates for sale. In today’s world...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Feb 4 2011
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, EMR, drugs, healthcare, EHR, Pharma, PHR, Prescriptions, data bases, Business Intelligence, Fines, personal health record, Algorithms, formulas, Express Scripts, overcharges, Vitality, Cobert Report, nsurance
-
Ok now we are coming full circle and hopefully by this time since November when I posted about the hotline created for propofol that has maybe evened out a little, but I wouldn’t hold my breath. We do not make any propofol in the US any longer and in 2 years went from 2 companies in the US to zero...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 3 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Surgery, drugs, healthcare, FDA, Recalls, Teva, Michael Jackson, Diprivan, Propofol, anesthesia, etomidate, Pentothal, Hospira
-
Around 5,530 employees will be cut from the Research and Development area and in the US, big losses in Connecticut. Lipitor is due to come off patent near the end of this year so sales will be impacted there. Lipitor has not been without issues either this last year as many bottles stunk...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 2 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Heart Disease, Pediatrics, Diabetes, Budgets, Pfizer, Research and Development, Lipitor, Job cuts, children, cholesterol, chewable
-
This is a good deal for developing nations getting drugs at an affordable price. This makes Johnson and Johnson the first pharma company to license generic copies before approval is even given. J and J licensed the drug for use in 48 countries listed as least developed countries to include...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Jan 30 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Pills, FDA, Generic Drugs, Patents, Johnson and Johnson, AIDS, licence, Tibotec, regulators
-
This is a game or situation that Johnson and Johnson seems to be good at with their multitude of legal cases with stents. This time they are on the losing end of the stick with a jury ruling they violated a patent. The same researcher also won a case against Boston Scientific on his design...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Jan 29 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Johnson and Johson
-
I won’t miss these commercials so I suppose there’s more room for Viagra and Cialis spots for sale on the networks. One of the reasons for stopping the commercials is an attempt from Glaxo to clean up their public image, as their president states. Recently Glaxo has has their world of problems...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jan 25 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Prescriptions, FDA, Advertising, ED, Glaxo Smith Kline, Levitra
-
Vilazodone is a modulator of serotonin neurotransmission to be used for treatment of Major Depression Disorders. Now there’s one more choice for depression, it’s amazing if you look how many of these are out there. BD From the website: “Nearly 2,900 patients have been exposed to vilazodone...